[Examinations of cattle births with a special focus on Coxiella burnetii].

Cattle births can carry the risk of transmissible and zoonotic diseases. The focus of the present study was the excretion of Coxiella (C.) burnetii during cattle births. Small ruminants are considered as the main reservoir of C. burnetii. Cattle are often subclinical carriers and their role as potential reservoir has not been fully elucidated until now, although the excretion of Coxiella has been demonstrated during cattle birth. The study recorded all births, caesarean sections and one abortion in 40 cattle at the ruminant clinic of the Vetsuisse Faculty in Bern in the study period from March 2019 to March 2020. A placenta -, milk - and fecal sample was examined for antigen diagnostics using polymerase chain reaction (PCR). In addition, a serum sample was analyzed to detect C. burnetii-specific antibodies. Antigen and/or antibodies (placenta, n=8/9; milk, n=2/9; faeces, n=1/9; serology n= 3/9) were detected in 22,5 % of the cows (n=9/40) without the presence of specific clinical symptoms. It is essential to sensitize contact persons to this zoonosis, since Coxiella can trigger Q-fever in humans

Phytotherapeutische Behandlungen gynäkologischer Erkrankungen und Fruchtbarkeitsstörungen von Rindern – eine veterinärhistorische Analyse

Fruchtbarkeitsprobleme sind die Hauptabgangsgründe von Milchkühen. Auch sind Erkrankungen des weiblichen Genitale häufig Ursache für antibiotische oder hormonelle Behandlungen in der Rinderpraxis. Die Anwendung von Arzneipflanzen könnte das verfügbare Therapiespektrum erweitern. Das Ziel der Arbeit war es, historische Literatur vor der Einführung der Antibiose in der Tiermedizin hinsichtlich des Einsatzes von Arzneipflanzen im Bereich der Veterinärgynäkologie zu analysieren. Sechs Quellen, fünf erschienen als deutschsprachige Bücher zwischen 1878 und 1921 in Deutschland und der Schweiz, eine war das handschriftlich verfasste Therapiebüchlein des Landtierarztes Carl Ammann-Honegger (1879–1960), wurden systematisch hinsichtlich Anwendungsbeschreibungen (AW) zu gynäkologischen Erkrankungen untersucht. Für jede AW wurden die pflanzlichen und weitere Bestandteile der Rezeptur, die Zieltierart, die Verabreichungsart und die Indikation detailliert erfasst. Die sechs Quellen enthielten insgesamt 103 AW (79 wurden oral, 13 lokal und 11 sowohl oral als auch lokal verabreicht). Bei knapp zwei Dritteln der AW (61) lag eine Pflanzenmischung (zwei bis sieben Pflanzen) zu Grunde, bei einem Drittel der AW (31) wurde eine einzelne Pflanzenart beschrieben. Insgesamt wurden 55 Pflanzenarten genannt. Die meistgenannten Arzneipflanzen waren Pflanzen der Gattung Juniperus (J. communis L.19 AW, J. sabina L.13 AW) sowie Linum usitatissimum L. (18 AW), Matricaria chamomilla L. (13 AW) und Gentiana lutea L. (12 AW). Mit 44 AW war die Behandlung der Retentio secundinarum die häufigst genannte Indikation, gefolgt von der Geburtsvorbereitung (17 AW) und der Endometritisbehandlung (15 AW). Aufgrund ihrer Inhaltstoffe und deren Wirkungsweisen liessen sich die am häufigsten genannten Pflanzen in (a) energie- und eiweissreiche Futterpflanzen, (b) allgemein appetitanregende verdauungs- und stoffwechselfördernde, (c) spezifisch gynäkologisch organotrop wirkende Arzneipflanzen und (d) nach aktueller Kenntnis vorwiegend toxische Pflanzen klassifizieren. Neben der Abwehrbereitschaft gegenüber bakteriellen Infektionen trägt in mindestens gleicher Weise eine stabile Abgrenzungsfunktion des Endometriums zur Gebärmuttergesundheit bei. Die unter (a) – (c) klassifizierten Pflanzen haben zumindest das Potential positiv auf Abwehrbereitschaft und Abgrenzungsfunktion zu wirken und somit indirekt die Gebärmuttergesundung und -gesunderhaltung zu fördern

[Phytotherapeutic treatments of gynecological diseases and fertility disorders in cattle - a veterinary historical analysis].

Fertility problems are the main reasons for culling dairy cows. Diseases of the female genital tract are also often the cause of antibiotic or hormonal treatments in bovine practices. The use of medicinal plants could expand the available therapeutics. The aim of the work was to analyze historical literature before the introduction of antibiotics in veterinary reproductive medicine. Five books in German language, published in Germany and Switzerland between 1878 and 1921, and one handwritten therapy booklet by the rural veterinarian Carl Ammann-Honegger (1879-1960) were systematically examined regarding the descriptions (AW) on gynecological diseases. The herbal and additional ingredients of the recipe, the target animal species, the type of administration and the indication were recorded in detail for each AW. The six literature sources contained a total of 103 AW (79 administered orally, 13 locally, and 11 both orally and locally). Almost two thirds of the AW (61) were based on a mixture of different plants (two to seven plants), and one third of the AW (31) on a single plant. A total of 55 plants were recorded. The most frequently mentioned medical plants were plants of the genus Juniperus (J. communis L. (19 AW), J. sabina L. (13 AW)) and Linum usitatissimum L. (18 AW), Matricaria chamomilla L. (13 AW) and Gentiana lutea L. (12 AW). The treatment of the Retentio secundinarum was the most frequently mentioned indication (44 AW), followed by parturition preparation (17 AW) and endometritis treatment (15 AW). The most frequently recorded plants can be divided based on their ingredients and their effect into (a) energy- and protein-rich forage plants, (b) generally appetizing, digestive- and metabolism-enhancing plants, (c) medical plants with a specific gynecological organotrophic effect and (d) according to current knowledge, predominantly toxic plants. Besides the antimicrobial active immunity to defence against bacterial infections, a stable barrier funcion of the endometrium contributes to uterine health. The plants classified under (a) - (c) have at least the potential for a positive effect on the immune system and the endometrial barrier function and thus contribute indirectly to the uterine health

Effects of a single administration of prostaglandin F2alpha, or a combination of prostaglandin F2alpha and prostaglandin E2, or placebo on fertility variables in dairy cows 3–5 weeks post partum, a randomized, double-blind clinical trial

BACKGROUND: Delayed uterine involution has negative effects on the fertility of cows; use of prostaglandin F2alpha alone as a single treatment has not been shown to consistently improve fertility. Combined administration of PGF2alpha and PGE2 increased uterine pressure in healthy cows. We hypothesized, that the combination of both prostaglandins would accelerate uterine involution and have, therefore, a positive effect on fertility variables. In commercial dairy farming, the benefit of a single post partum combined prostaglandin treatment should be demonstrated. METHODS: 383 cows from commercial dairy farms were included in this study. Uterine size and secretion were evaluated at treatment 21–35 days post partum and 14 days later. Cows were randomly allocated to one of three treatment groups: PGF2alpha and PGE2, PGF2alpha or placebo. For every animal participating in the study, the following reproduction variables were recorded: Interval from calving to first insemination, days open, number of artificial inseminations (AI) to conception; subsequent treatment of uterus, subsequent treatment of ovaries. Plasma progesterone level at time of treatment was used as a covariable. For continuous measurements, analysis of variance was performed. Fisher's exact test for categorical non-ordered data and exact Kruskal-Wallis test for ordered data were used; pairwise group comparisons with Bonferroni adjustment of significance level were performed. RESULTS: There was no significant difference among treatment groups in uterine size. Furthermore, there was no significant difference among treatments concerning days open, number of AI, and subsequent treatment of uterus and ovaries. Days from calving to first insemination tended to be shorter for cows with low progesterone level given PGF2alpha and PGE2 in combination than for the placebo-group (P = 0.024). CONCLUSION: The results of this study indicate that the administration of PGF2alpha or a combination of PGF2alpha and PGE2 21 to 35 days post partum had no beneficial effect upon measured fertility variables. The exception was a tendency for a shorter interval from calving to first insemination after administration of the combination of PGF2alpha and PGE2, as compared to the placebo group. Further research should be done in herds with reduced fertility and/or an increased incidence of postpartum vaginal discharge

[Unclear fertility-related losses in cattle - a pilot study to evaluate the occurrence of bovine endometrosis].

With every surgical procedure there is a risk of postoperative infection (surgical site infection = SSI). This risk of infection can be influenced by various factors, including perioperative antibiotic prophylaxis. In terms of antibiotic stewardship, antibiotics should only be used if there is a proven benefit for the patient. However, this advantage has not yet been conclusively proven, especially for clean and clean-contaminated surgeries. The aim of our study was to document various relevant influencing factors on the infection rate after clean and clean-contaminated surgeries in dogs and cats. In particular, it was documented to what extent a reduced use of antibiotics affects the infection rate in the context of all influencing factors. Over a period of eleven months, 807 clean and clean-contaminated surgeries in dogs and cats were prospectively analyzed with possible influencing factors (gender, ASA classification, underlying endocrinological diseases, duration of anesthesia, duration of surgery, type of surgery, perioperative antibiotic prophylaxis (POA), duration of hospitalization) affecting the infection rate. After surgery all cases were followed up either 30 or 90 days, if implants were used. The effect of the various factors was evaluated using multivariable logistic regression analysis. SSI was detected in 25/664 clean and 10/143 clean-contaminated surgeries. Longer hospitalization, without antimicrobial prophylaxis, and male animals had a significantly higher risk of SSI. In clean surgeries, SSI occurred in 2,3 % of all cases with POA and 5,3 % without POA. The SSI in clean-contaminated was 3,6 % with POA and 9 % without. This difference resulted mainly from the results of osteosynthesis, gastrointestinal and skin surgeries. However, other types of surgeries, such as castrations, neurological interventions, abdominal and thoracic surgeries, and surgeries in the head and neck region, showed comparable infection rates with and without POA

Case series on granulosa cell tumour in cattle with practical hints on diagnostics and outcome

Granulosa cell tumours are the most common neoplasm of the bovine ovary and present with a wide range of clinical signs. This case series comprises five case reports of ovarian granulosa cell tumours in cattle. The affected animals had different breeds (Red Holstein, Eringer, Swiss Braunvieh, crossbred beef) and ranged in age from 1 year 4 months to 20 years 11 months. The diversity of the cases gives an overview of the diagnostic possibilities as well as the possible treatments and outcomes of the disease. Anti-mullerian hormone (AMH) was measured in one of the affected animals, and was extremely elevated (>150 pmoL/L) compared to reported normal values (<3 pmoL/L). Three animals underwent standing laparotomy with unilateral ovariectomy, and the remaining two animals were slaughtered. One of the cases confirms the previously published reports that malignancy or metastasis is possible in cattle. Another case indicates that successful surgical treatment with subsequent resumption of reproduction is possible. In summary, the initial tentative diagnosis of GCT is made by ultrasound-assisted rectal examination of the genital tract or ovaries and can subsequently be supported by evaluation of AMH levels. The decision to proceed with treatment should be made without delay, as surgical removal of the altered ovary with subsequent resumption of reproductive activity and cessation of undesirable behaviour is possible

Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial

BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT). The IONDT was a multicenter study that included randomized and non-randomized patients with newly diagnosed NAION in the study eye. At baseline, randomized eyes had visual acuity of 20/64 or worse and non-randomized eyes had visual acuity of better than 20/64 or were associated with patients refusing randomization. Visual fields were measured before treatment using the Humphrey Field Analyzer with the 24-2 program, foveal threshold, and size III stimulus. METHODS: We used visual fields from 189 non-IONDT eyes with NAION to develop the computerized classification system. Six neuro-ophthalmologists ("expert panel") described definitions for visual field patterns defects using 19 visual fields representing a range of pattern defect types. The expert panel then used 120 visual fields, classified using these definitions, to refine the rules, generating revised definitions for 13 visual field pattern defects and 3 levels of severity. These definitions were incorporated into a rule-based computerized classification system run on Excel(® )software. The computerized classification system was used to categorize visual field defects for an additional 95 NAION visual fields, and the expert panel was asked to independently classify the new fields and subsequently whether they agreed with the computer classification. To account for test variability over time, we derived an adjustment factor from the pooled short term fluctuation. We examined change in defects with and without adjustment in visual fields of study participants who demonstrated a visual acuity decrease within 30 days of NAION onset (progressive NAION). RESULTS: Despite an agreed upon set of rules, there was not good agreement among the expert panel when their independent visual classifications were compared. A majority did concur with the computer classification for 91 of 95 visual fields. Remaining classification discrepancies could not be resolved without modifying existing definitions. Without using the adjustment factor, visual fields of 63.6% (14/22) patients with progressive NAION and no central defect, and all (7/7) patients with a paracentral defect, worsened within 30 days of NAION onset. After applying the adjustment factor, the visual fields of the same patients with no initial central defect and 5/7 of the patients with a paracentral defect were seen to worsen. CONCLUSION: The IONDT developed a rule-based computerized system that consistently defines pattern and severity of visual fields of NAION patients for use in a research setting